No Data
No Data
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a gift.
Teck CEO Sees $3B in Annual EBITDA at $5/lb Copper; Stock Hits Multiyear High
19 Stocks and ETFs to Benefit From the Electrification Theme and Future Energy Technologies - BofA
CNBC Halftime Report Final Trades: Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals, QUALCOMM
CNBC Halftime Report Final Trades: Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals, QUALCOMM
Most Shorted S&P 500 Materials Stocks in April
Unveiling 8 Analyst Insights On Freeport-McMoRan
8 analysts have shared their evaluations of Freeport-McMoRan (NYSE:FCX) during the recent three months, expressing a mix of bullish and bearish perspectives.The following table summarizes their recent